Submission for OMB Review; National Advisory Committee on the Sex Trafficking of Children and Youth in the United States (NAC) Recommendations and State Self-Assessment Survey (NEW), 61752-61753 [2020-21617]
Download as PDF
<![CDATA[
61752
Federal Register / Vol. 85, No. 190 / Wednesday, September 30, 2020 / Notices
Jeffery M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2020–21621 Filed 9–29–20; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, CDC, pursuant to
Public Law 92–463. The grant
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the grant applications, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)—
DD21–001, Study to Explore Early
Development (SEED) Follow up Studies.
Date: January 12–13, 2021.
Time: 10:00 a.m.–6:00 p.m., EST.
Place: Teleconference.
Agenda: To review and evaluate grant
applications.
For Further Information Contact: Jaya
Raman Ph.D., Scientific Review Officer,
CDC, 4770 Buford Highway, Mailstop
S107–8, Atlanta, Georgia 30341,
Telephone: (770) 488–6511, JRaman@
cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2020–21604 Filed 9–29–20; 8:45 am]
decision concerning the collection of
information between 30 and 60 days
after publication of this document in the
Federal Register. Therefore, a comment
is best assured of having its full effect
if OMB receives it within 30 days of
publication.
Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function.
ADDRESSES:
SUPPLEMENTARY INFORMATION:
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Submission for OMB Review; National
Advisory Committee on the Sex
Trafficking of Children and Youth in
the United States (NAC)
Recommendations and State SelfAssessment Survey (NEW)
Office on Trafficking in
Persons, Administration for Children
and Families, HHS.
ACTION: Request for public comment.
AGENCY:
The Office on Trafficking in
Persons (OTIP), Administration for
Children and Families (ACF), U.S.
Department of Health and Human
Services (HHS), is proposing to collect
data for a new survey, the National
Advisory Committee on the Sex
Trafficking of Children and Youth in the
United States (NAC) Recommendations
and State Self-Assessment Survey.
DATES: Comments due within 30 days of
publication. OMB is required to make a
SUMMARY:
Description: The Preventing Sex
Trafficking and Strengthening Families
Act of 2014 mandated the NAC to
develop a report describing how each
state and territory has implemented its
recommendations to address sex
trafficking in children and youth. The
NAC proposes to administer a survey
allowing states to assess their progress
in implementing NAC
recommendations. Submissions will
allow states to document their efforts in
the following sections:
Multidisciplinary Response, Screening
and Identification, Child Welfare,
Service Provision, Housing, Law
Enforcement and Prosecution, Judiciary,
Demand Reduction, Prevention,
Legislation and Regulation, Research
and Data, and Funding. Each state will
have the opportunity to provide a selfassessed tier ranking for each
recommendation, a justification of their
assessment, sources for their
assessment, and the public or private
nature of those sources.
Respondents: State Governors, Child
Welfare Agencies, Local Law
Enforcement, and Other Local Agencies.
Annual Burden Estimates:
ESTIMATED OPPORTUNITY COSTS FOR RESPONDENTS
Instrument
Total number
of respondents
contributing for
50 states
Total number of
responses per
respondent
250
1
jbell on DSKJLSW7X2PROD with NOTICES
NAC Recommendations and State Self-Assessment Survey .......................
Estimated Total Annual Burden
Hours: 1,713.
VerDate Sep<11>2014
17:36 Sep 29, 2020
Jkt 250001
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
E:\FR\FM\30SEN1.SGM
30SEN1
Average
burden hours
per response
6.85
Total/annual
burden hours
1,713
61753
Federal Register / Vol. 85, No. 190 / Wednesday, September 30, 2020 / Notices
ESTIMATED RECORDKEEPING COSTS
Instrument
Total number
of respondents
Total number of
responses per
respondent
50
1
NAC Recommendations and State Self-Assessment Survey .......................
Estimated Total Annual Burden
Hours: 2,000
(Authority: 42 U.S.C. 1314b)
John M. Sweet Jr.,
ACF/OPRE Certifying Officer.
[FR Doc. 2020–21617 Filed 9–29–20; 8:45 am]
BILLING CODE 4184–47–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2020–D–1791]
E14 and S7B Clinical and Nonclinical
Evaluation of QT/QTc Interval
Prolongation and Proarrhythmic
Potential—Questions and Answers;
International Council for
Harmonisation; Draft Guidance for
Industry; Availability
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice of availability.
The Food and Drug
Administration (FDA or Agency) is
announcing the availability of a draft
guidance for industry entitled ‘‘E14 and
S7B Clinical and Nonclinical Evaluation
of QT/QTc Interval Prolongation and
Proarrhythmic Potential—Questions and
Answers.’’ The draft guidance was
prepared under the auspices of the
International Council for Harmonisation
of Technical Requirements for
Pharmaceuticals for Human Use (ICH),
formerly the International Conference
on Harmonisation of Technical
Requirements for Registration of
Pharmaceuticals for Human Use. The
draft guidance contains revised
questions and answers (Q&As) for the
ICH guidance for industry ‘‘E14 Clinical
Evaluation of the QT/QTc Interval
Prolongation and Proarrhythmic
Potential for Non-Antiarrhythmic
Drugs’’ and new Q&As for the ICH
guidance for industry ‘‘S7B Nonclinical
Evaluation of the Potential for Delayed
Ventricular Repolarization (QT Interval
Prolongation) by Human
Pharmaceuticals’’ that provide
recommendations on considerations for
an integrated risk assessment combining
nonclinical and clinical data—in
particular, at later stages of drug
jbell on DSKJLSW7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:36 Sep 29, 2020
Jkt 250001
development when clinical data are
available. The draft guidance is
intended to provide a harmonized
approach to integrate nonclinical and
clinical information for proarrhythmia
risk assessment to streamline drug
development and provide clarity on
regulatory decision making.
DATES: Submit either electronic or
written comments on the draft guidance
by November 30, 2020 to ensure that the
Agency considers your comment on this
draft guidance before it begins work on
the final version of the guidance.
ADDRESSES: You may submit comments
on any guidance at any time as follows:
Electronic Submissions
Submit electronic comments in the
following way:
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
Comments submitted electronically,
including attachments, to https://
www.regulations.gov will be posted to
the docket unchanged. Because your
comment will be made public, you are
solely responsible for ensuring that your
comment does not include any
confidential information that you or a
third party may not wish to be posted,
such as medical information, your or
anyone else’s Social Security number, or
confidential business information, such
as a manufacturing process. Please note
that if you include your name, contact
information, or other information that
identifies you in the body of your
comments, that information will be
posted on https://www.regulations.gov.
• If you want to submit a comment
with confidential information that you
do not wish to be made available to the
public, submit the comment as a
written/paper submission and in the
manner detailed (see ‘‘Written/Paper
Submissions’’ and ‘‘Instructions’’).
Written/Paper Submissions
Submit written/paper submissions as
follows:
• Mail/Hand Delivery/Courier (for
written/paper submissions): Dockets
Management Staff (HFA–305), Food and
Drug Administration, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.
• For written/paper comments
submitted to the Dockets Management
Staff, FDA will post your comment, as
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
Average
burden hours
per response
40
Total/annual
burden hours
2,000.
well as any attachments, except for
information submitted, marked and
identified, as confidential, if submitted
as detailed in ‘‘Instructions.’’
Instructions: All submissions received
must include the Docket No. FDA–
2020–D–1791 for ‘‘E14 and S7B Clinical
and Nonclinical Evaluation of QT/QTc
Interval Prolongation and Proarrhythmic
Potential—Questions and Answers’’
Received comments will be placed in
the docket and, except for those
submitted as ‘‘Confidential
Submissions,’’ publicly viewable at
https://www.regulations.gov or at the
Dockets Management Staff between 9
a.m. and 4 p.m., Monday through
Friday, 240–402–7500.
• Confidential Submissions—To
submit a comment with confidential
information that you do not wish to be
made publicly available, submit your
comments only as a written/paper
submission. You should submit two
copies total. One copy will include the
information you claim to be confidential
with a heading or cover note that states
‘‘THIS DOCUMENT CONTAINS
CONFIDENTIAL INFORMATION.’’ The
Agency will review this copy, including
the claimed confidential information, in
its consideration of comments. The
second copy, which will have the
claimed confidential information
redacted/blacked out, will be available
for public viewing and posted on
https://www.regulations.gov. Submit
both copies to the Dockets Management
Staff. If you do not wish your name and
contact information to be made publicly
available, you can provide this
information on the cover sheet and not
in the body of your comments and you
must identify this information as
‘‘confidential.’’ Any information marked
as ‘‘confidential’’ will not be disclosed
except in accordance with 21 CFR 10.20
and other applicable disclosure law. For
more information about FDA’s posting
of comments to public dockets, see 80
FR 56469, September 18, 2015, or access
the information at: https://
www.govinfo.gov/content/pkg/FR-201509-18/pdf/2015-23389.pdf.
Docket: For access to the docket to
read background documents or the
electronic and written/paper comments
received, go to https://
www.regulations.gov and insert the
docket number, found in brackets in the
E:\FR\FM\30SEN1.SGM
30SEN1
]]>Agencies
[Federal Register Volume 85, Number 190 (Wednesday, September 30, 2020)]
[Notices]
[Pages 61752-61753]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-21617]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Administration for Children and Families
Submission for OMB Review; National Advisory Committee on the Sex
Trafficking of Children and Youth in the United States (NAC)
Recommendations and State Self-Assessment Survey (NEW)
AGENCY: Office on Trafficking in Persons, Administration for Children
and Families, HHS.
ACTION: Request for public comment.
-----------------------------------------------------------------------
SUMMARY: The Office on Trafficking in Persons (OTIP), Administration
for Children and Families (ACF), U.S. Department of Health and Human
Services (HHS), is proposing to collect data for a new survey, the
National Advisory Committee on the Sex Trafficking of Children and
Youth in the United States (NAC) Recommendations and State Self-
Assessment Survey.
DATES: Comments due within 30 days of publication. OMB is required to
make a decision concerning the collection of information between 30 and
60 days after publication of this document in the Federal Register.
Therefore, a comment is best assured of having its full effect if OMB
receives it within 30 days of publication.
ADDRESSES: Written comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function.
SUPPLEMENTARY INFORMATION:
Description: The Preventing Sex Trafficking and Strengthening
Families Act of 2014 mandated the NAC to develop a report describing
how each state and territory has implemented its recommendations to
address sex trafficking in children and youth. The NAC proposes to
administer a survey allowing states to assess their progress in
implementing NAC recommendations. Submissions will allow states to
document their efforts in the following sections: Multidisciplinary
Response, Screening and Identification, Child Welfare, Service
Provision, Housing, Law Enforcement and Prosecution, Judiciary, Demand
Reduction, Prevention, Legislation and Regulation, Research and Data,
and Funding. Each state will have the opportunity to provide a self-
assessed tier ranking for each recommendation, a justification of their
assessment, sources for their assessment, and the public or private
nature of those sources.
Respondents: State Governors, Child Welfare Agencies, Local Law
Enforcement, and Other Local Agencies.
Annual Burden Estimates:
Estimated Opportunity Costs for Respondents
----------------------------------------------------------------------------------------------------------------
Total number
of respondents Total number of Average Total/annual
Instrument contributing responses per burden hours burden hours
for 50 states respondent per response
----------------------------------------------------------------------------------------------------------------
NAC Recommendations and State Self-Assessment 250 1 6.85 1,713
Survey........................................
----------------------------------------------------------------------------------------------------------------
Estimated Total Annual Burden Hours: 1,713.
[[Page 61753]]
Estimated Recordkeeping Costs
----------------------------------------------------------------------------------------------------------------
Total number of Average
Instrument Total number responses per burden hours Total/annual
of respondents respondent per response burden hours
----------------------------------------------------------------------------------------------------------------
NAC Recommendations and State Self-Assessment 50 1 40 2,000.
Survey........................................
----------------------------------------------------------------------------------------------------------------
Estimated Total Annual Burden Hours: 2,000
(Authority: 42 U.S.C. 1314b)
John M. Sweet Jr.,
ACF/OPRE Certifying Officer.
[FR Doc. 2020-21617 Filed 9-29-20; 8:45 am]
BILLING CODE 4184-47-P
